User:EuroMedChem/sandbox

Introduction
The European Federation for Medicinal Chemistry (EFMC) is an independent non-profit association founded on December 19, 1969 that represents 26 scientific organisations from 24 European countries, i.e. over 7500 scientists.

Its objective is to advance the science of medicinal chemistry & chemical biology by promoting cooperation and encouraging strong links between the national adhering organisations in order to deepen contacts and exchanges between medicinal chemists & chemical biologists in Europe and around the World.

Since 2018, Yves P. Auberson, Executive Director, Global Discovery Chemistry at Novartis Institutes for BioMedical Research has been President of the EFMC. On September 1, 2019, the Council of the EFMC elected Prof. Rui Moreira of University of Lisbon as EFMC President Elect. His three-year term as President will begin in January 2021.

Aims and function
EFMC fulfils the objective of advancing the science of medicinal chemistry & chemical biology by organizing symposia and short courses, by sponsoring meetings and medicinal chemistry schools, by publishing on relevant topics and by conferring awards and prizes.

Its most important organisation is the biennial International Symposium on Medicinal Chemistry (EFMC-ISMC). These symposia, with an average attendance of 1,000 delegates, are highly international with a broad range of speakers and attendees from the pharmaceutical industry and academia. Besides EFMC-ISMC, EFMC is involved in the organisation of the Frontiers in Medicinal Chemistry (FMC), the international symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC) and the Young Medicinal Chemists Symposium (EFMC-YMCS). EFMC also organises intensive short courses on specific topics in medicinal chemistry.

An important part of the EFMC activities is sponsorship of national scientific meetings and Medicinal Chemistry Schools. EFMC also awards travel grants for younger scientists to attend EFMC symposia and schools. EFMC is publishing the electronic newsletter MedChemWatch as well as the yearbook “Medicinal Chemistry in Europe” aiming to further develop contacts between medicinal chemists around the world.

EFMC also acknowledges the excellence of medicinal chemists’ work, by conferring three major awards: the Nauta Pharmacochemistry Award for Medicinal Chemistry and Chemical Biology, the UCB-Ehrlich Award for Excellence in Medicinal Chemistry and the Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery, which are given every two years for outstanding achievements in the field of Medicinal Chemistry.

From 2010 on, EFMC established two new prizes to acknowledge the scientific accomplishments of young medicinal chemists, both in industry and academia.

National Adhering Organisations
The EFMC represents 26 scientific organisations from 24 European countries.


 * Medicinal Chemistry Section of the Austrian Chemical Society, Austria
 * Medicinal and Bioorganic Chemistry Division of the Royal Flemish Chemical Society (KVCV), Belgium
 * Medicinal Chemistry Section of the Société Royale de Chimie (SRC), Belgium
 * Section of Medicinal/Pharmaceutical Chemistry of the Croatian Chemical Society, Croatia
 * Section of Synthetic Drug of the Czech Pharmaceutical Society, Czech Republic
 * The Danish Society for Medicinal Chemistry and Chemical Biology, Denmark
 * Finnish Pharmaceutical Society, Finland
 * Société de Chimie Thérapeutique (SCT), France
 * Division of Medicinal Chemistry of the German Chemical Society (GDCh), Germany
 * Section of Pharmaceutical/Medicinal Chemistry of the German Pharmaceutical Society (DPhG), Germany
 * Hellenic Society of Medicinal Chemistry, Greece
 * Organic and Medicinal Chemistry Division (OMCD) of the Hungarian Chemical Society (HCS), Hungary
 * The Medicinal Chemistry Section of the Israel Chemical Society, Israel
 * Division of Medicinal Chemistry of the Italian Chemical Society (Società Chimica Italiana), Italy
 * Latvian Association for Medicinal Chemistry, Latvia
 * Polish Society of Medicinal Chemistry, Poland
 * Division of Medicinal Chemistry of the Portuguese Chemical Society, Portugal
 * Medicinal Chemistry Section of The D.I. Mendeleev Russian Chemical Society, Russia
 * Division of Medicinal Chemistry of the Serbian Chemical Society, Serbia
 * Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society, Slovenia
 * Sociedad Española de Química Terapéutica, Spain
 * The Swedish Academy of Pharmaceutical Sciences, Sweden
 * Division of Medicinal Chemistry & Chemical Biology (DMCCB) of the Swiss Chemical Society, Switzerland
 * Section Medicinal Chemistry of the Royal Netherlands Chemical Society (KNCV), The Netherlands
 * Turkish Association of Medicinal and Pharmaceutical Chemistry, Turkey
 * The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC), United Kingdom

The EFMC also maintains partnerships with the following organisations:


 * ACS Division of Medicinal Chemistry (ACSMEDI)
 * Asian Federation for Medicinal Chemistry (AFMC)
 * Brazilian Chemical Society (SBQ)
 * Chinese Pharmaceutical Association (CPA)
 * European Chemical Society (EuChemS)
 * European Federation for Pharmaceutical Science (Eufeps)
 * International Chemical Biology Society (ICBS)

EFMC-ISMC
EFMC has been organizing the EFMC-ISMC since the 1970s, although the roots of the conference series “International Symposium on Medicinal Chemistry” go back to 1962. The European Federation for Medicinal Chemistry (EFMC) is sponsor of this series of symposia, each of which is organised in a European city in collaboration with one or more EFMC National Adhering Organisation/s (NAO).

The congresses have taken place in: Florence (1962), Muenster (1968), Milano (1972), Noordwijkerhout (1974), Paris (1976), Brighton (1978), Torremolinos (1980), Uppsala (1984), Berlin (1986), Budapest (1988), Jerusalem (1990), Basel (1992), Paris (19934), Maastricht (1996), Edinburgh (1998), Bologna (2000), Barcelona (2002), Copenhagen-Lund (2004), Istanbul (2006), Vienna (2008), Brussels (2010), Berlin (2012) Lisbon (2014), Manchester (2016), Ljubljana (2018). The 2020 edition will be organised in Basel.

The EFMC-ISMC usually attract some 1000 chemists from more than 50 countries across the world.

EFMC-ASMC
The European Federation for Medicinal Chemistry (EFMC) and ChemBridge Corporation have been organising since 2004 the successful series of the International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC).

The congresses have taken place in: Moscow in 2004, St. Petersburg in 2007, Kiev in 2009, St. Petersburg in 2011, Moscow in 2013, Rehovot in 2015, Vienna in 2017 and Athens in 2019. The 2021 edition will be organised in Zagreb.

EFMC-ACSMEDI Medicinal Chemistry Frontiers
The Frontiers in Medicinal Chemistry symposium is co-organised on a biennial basis, as a collaboration between the ACS-MEDI (American Chemical Society - Medicinal Chemistry Division) and the EFMC (European Federation for Medicinal Chemistry). The goal of the symposium is to build and sustain bridges between the European and American Medicinal Chemistry Communities, and to showcase a specific region and its related Medicinal Chemistry activities to the participants.

The congresses have taken place in: Sienna (2007), Barcelona (2009), Stockholm (2011), San Francisco (2013), Antwerp (2015), Philadelphia (2017), Krakow (2019).

EFMC-YMCS
The EFMC Young Medicinal Chemist Symposium is an initiative of the European Federation for Medicinal Chemistry (EFMC). This short symposium has the aims of creating a network of young European researchers in Medicinal Chemistry, stimulating them to share their scientific work with peers and inspiring leaders in the field, and creating competition and excellence in Medicinal Chemistry within Europe by selecting the European Champion in Medicinal Chemistry.

The congresses have taken place in: Lisbon (2014), Antwerp (2015), Manchester (2016), Vienna (2017), Ljubljana (2018) and Athens (2019). The 2020 edition will be organised in Basel.

Short Courses
The EFMC Short Courses are an initiative of the European Federation for Medicinal Chemistry (EFMC), established as a training tool for today’s medicinal chemists, especially young scientists.

The annual Short Course series started in 2009, addressing a broad range of selected topics such as Safety and Attrition, Principles of Molecular Recognition, PPIs, Modulation of Enzymes, Kinetic Perspective on Drug-Target Interactions and Peptides Therapeutics.

Awards
==== Nauta Pharmacochemistry Award for Medicinal Chemistry and Chemical Biology ====

The "Nauta Pharmacochemistry Award for Medicinal Chemistry and Chemical Biology" was established to honour the memory of Prof. Dr. W. Th. Nauta, whose activities have been very important for the advancement of Medicinal Chemistry in general, and the development of international organisational structures for this discipline.

The Nauta Award will acknowledges outstanding results of scientific research in the field of Medicinal Chemistry obtained by scientists without restriction regarding nationality. The award is given biennially and consists of a diploma, € 7.500 and an invitation to present a lecture at an EFMC-ISMC symposium.

UCB-Ehrlich Award for Excellence in Medicinal Chemistry
The “UCB-Ehrlich Award for Excellence in Medicinal Chemistry” was established to acknowledge and recognise outstanding research in the field of Medicinal Chemistry in its broadest sense. The Award is given biennially and consists of a diploma, € 7.500 and an invitation to present a lecture at an EFMC-ISMC symposium.

The Award is open to any scientist whose age does not exceed 50 years on January 1st of the year during which the Award is to be presented.

==== Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery ====

The "Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery" was established to encourage innovation and investigation in technologies related to drug discovery. The Award is given biennially to acknowledge the discovery, evaluation or use of a new technology, and consists of a diploma, € 7.500 and an invitation to present a lecture at an EFMC-ISMC symposium.

EFMC Prize for a Young Medicinal Chemist in Academia & Industry
Launched in 2010 to acknowledge and recognise outstanding young medicinal chemists (≤ 12 years after PhD) working in European industry and academia. The two Prizes are given annually and consists of a diploma, € 1.000 and an invitation for a short presentation at an EFMC symposium.

EFMC-YSN Prize
Launched in 2020 by the Young Scientists Network (YSN) of the EFMC to recognise a worthy European PhD student (or up to one year after PhD). The Prize consists of a diploma, a free registration and a 500€ travel grant to attend the XXVI EFMC International Symposium on Medicinal Chemistry and EFMC Young Medicinal Chemist Symposium.